Overview

Public BiotechLSD

Developing RE104 (psilocybin) and proprietary delivery technologies.

Visit Website

Toronto, Canada

$80M
Market Cap
2021
Founded
25
Employees
0
Open Roles

Open Positions

No open positions at this time

Clinical Pipeline(1)

Unknown·N/A·LSD

Investigating Lysosomal Storage Diseases in Minority Groups

Lysosomal Storage Disorders
NCT02120235